Nitromed CFO Kenneth Bate will succeed interim CEO Jerry Karabelas, the company announces Jan. 22. Bate joined Nitromed in March as part of a management shake-up to jump-start sales of the firm's heart failure therapy for African Americans, BiDil (1"The Pink Sheet" March 27, 2006, p. 14). Bate has held vice president positions at Millennium and Biogen Idec...
You may also be interested in...
NitroMed's strategy for jump-starting sales of BiDil includes renewed efforts to get favorable formulary placement for the heart failure drug
Nina Daily, chief marketing officer at the Professional Beauty Association since July 2018, will succeed Steve Sleeper as executive director at the end of June when Sleeper retires. More cosmetics industry appointments.
Third round of orders would give the US all the vaccine it needs from the existing mRNA products, taking pressure off AstraZeneca as it experiences manufacturing challenges and the EU considers export restrictions to ensure it gets enough vaccine.